Legal & General Group PLC Aspira Women'S Health Inc. Transaction History

Legal & General Group PLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 22, 2022	SELL	$0.4 - $1.09 $41,411 - $112,846	-103,529 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.88 - $1.81 $2,571 - $5,288	-2,922 Reduced 2.74%	103,529 $107,000
Q4 2021 Feb 14, 2022	BUY	$1.63 - $3.43 $144,846 - $304,800	88,863 Added 505.25%	106,451 $189,000
Q3 2021 Nov 15, 2021	BUY	$3.19 - $5.48 $31,692 - $54,443	9,935 Added 129.82%	17,588 $57,000
Q2 2021 Aug 12, 2021	SELL	$4.78 - $6.84 $8,365 - $11,970	-1,750 Reduced 18.61%	7,653 $43,000
Q1 2021 May 17, 2021	SELL	$5.9 - $9.13 $204,765 - $316,865	-34,706 Reduced 78.68%	9,403 $63,000
Q4 2020 Feb 12, 2021	BUY	$3.0 - $6.71 $104,535 - $233,809	34,845 Added 376.13%	44,109 $296,000
Q3 2020 Nov 13, 2020	BUY	$2.54 - $4.56 $3,962 - $7,113	1,560 Added 20.25%	9,264 $29,000
Q2 2020 Aug 14, 2020	BUY	$0.78 - $5.25 $6,009 - $40,446	7,704 New	7,704 $30,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.